{"disease":{"id":"corneal-ulcer","name":"Corneal ulcer","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":9,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Allergic corneal marginal ulcers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Allergic corneal marginal ulcers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fml","generic_name":"FLUOROMETHOLONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"medrysone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrifar","generic_name":"MEDRYSONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"ciprofloxacine","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ciprofloxacine","company_name":"Poitiers University Hospital","drug_phase":"discontinued","molecular_target":"DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone-acetate","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flarex","generic_name":"FLUOROMETHOLONE ACETATE","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Floxin","generic_name":"OFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H3 receptor","drug_class":"Quinolone Antimicrobial [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"ciprofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cipro","generic_name":"ciprofloxacin","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A","drug_class":"Fluoroquinolone antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levaquin","generic_name":"levofloxacin","company_name":"Generic (originally Daiichi Sankyo/J&J)","drug_phase":"marketed","molecular_target":"CAAX prenyl protease 2, Multidrug and toxin extrusion protein 1, Potassium voltage-gated channel subfamily H member 2","drug_class":"Fluoroquinolone Antibacterial [EPC]","quality_score":65,"revenue":null,"mechanism":"Levofloxacin is a fluoroquinolone antibacterial agent."},{"drug_id":"cortisol","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ofloxacine","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ofloxacine","company_name":"Assistance Publique - Hôpitaux de Paris","drug_phase":"phase_3","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":17,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04164407","title":"Keratoconus, Corneal Diseases and Transplant Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05255016","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":488,"lead_sponsor_name":"Peschke GmbH","has_results":false},{"nct_id":"NCT05255107","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":468,"lead_sponsor_name":"Peschke GmbH","has_results":false},{"nct_id":"NCT04837534","title":"Improving the Follow up Rate for Pediatric Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"Seva Foundation","has_results":false},{"nct_id":"NCT07308938","title":"Fluorometholone Study","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":174,"lead_sponsor_name":"Vishal Jhanji","has_results":false},{"nct_id":"NCT06658002","title":"Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06540131","title":"Studying the Effect of Ethanol Applied on the Corneal Surface During PRK Surgery.","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT07394257","title":"Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT05891106","title":"AONDA Therapeutic Indication Study I","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Alcon Research","has_results":false},{"nct_id":"NCT07148752","title":"Evaluation of Resveratrol and Its Loaded Nanoparticles on Acanthamoeba","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05313828","title":"Effect of Various Treatment Modalities on Dendritic Vial Ulcer","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT06909149","title":"Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT05705024","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"University of Illinois at Chicago","has_results":false},{"nct_id":"NCT05940376","title":"Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT04484402","title":"Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus","has_results":false},{"nct_id":"NCT04820010","title":"Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.","has_results":false},{"nct_id":"NCT05200000","title":"Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"TBF Genie Tissulaire","has_results":false},{"nct_id":"NCT01765244","title":"Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud","has_results":false},{"nct_id":"NCT04573647","title":"OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Sight Medical Doctors PLLC","has_results":false},{"nct_id":"NCT04054817","title":"ACRO Biocornea Clinical Trial in Taiwan","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"ACRO Biomedical Co. Ltd","has_results":false},{"nct_id":"NCT05809245","title":"Corneal Neurotization as a Treatment for Neurotrophic Keratopathy","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04850313","title":"Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Arkansas","has_results":true},{"nct_id":"NCT06411145","title":"Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":false},{"nct_id":"NCT04230811","title":"Diagnosing Corneal Infection","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Edinburgh","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}